UNSPSC 51422348: Fluperolone acetate

This classification denotes a fluprednisolone analog C24H31FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DOL7Q9DPF9, chemically known as androsta-1,4-dien-3-one, 17-(2-(acetyloxy)-1-oxopropyl)-9-fluoro-11,17-dihydroxy-, (11.beta.,17.alpha.,17(s))-, but more generally known as fluperolone acetate, which bears US NIH Compound Identifier 66257. Most nations, for tariff and trade purposes, schedule fluperolone acetate under HS 29372200 and SITC 54153.

As of Q4 2014, FLUPEROLONE ACETATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@@H](C(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)O)OC(=O)C.

UNSPSC 51422348 Fluperolone acetate is a Commodity code with minimal relevant recent state and local procurement activity. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS—is tagged to this code but solicits naloxone and drug deactivation systems, which do not align with the pharmaceutical steroid compound that the code nominally describes. This mismatch suggests either a tagging error in the source data or a gap in how the jurisdiction categorized its procurement. No other recent state and local opportunities under this code appear in the available records.

Seminole County, Florida posted the naloxone and deactivation-systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (an internally inconsistent date range in the source). The procurement sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, with a two-year initial term and one-year renewal option. Bidders were required to submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs, maintain specified insurance coverage, and comply with E-Verify and drug-free workplace requirements. The contract was potentially funded through FEMA, introducing additional federal compliance obligations. Given the sparse activity and the evident mismatch between the code and the single opportunity cited, this code does not currently represent actionable state and local procurement volume for vendors supplying fluperolone acetate or related pharmaceutical compounds.